Full metadata record
DC FieldValueLanguage
dc.contributor.authorChen, C.Z.C.-
dc.contributor.authorFish, P.V.-
dc.contributor.authorPeng, Y.X.-
dc.contributor.authorWang, Z.B.-
dc.contributor.authorKaar, J.L.-
dc.contributor.authorKoepsel, R.R.-
dc.contributor.authorRussell, A.J .-
dc.contributor.authorLareu, R.R.-
dc.contributor.authorRaghunath, M.-
dc.date.accessioned2018-10-29T09:25:22Z-
dc.date.available2018-10-29T09:25:22Z-
dc.date.issued2009-
dc.identifier.issn1476-5381de_CH
dc.identifier.issn0007-1188de_CH
dc.identifier.urihttps://digitalcollection.zhaw.ch/handle/11475/12213-
dc.description.abstractBackground and purpose: Fibrosis, a pathological accumulation of collagen in tissues, represents a major global disease burden. Effective characterization of potential antifibrotic drugs has been constrained by poor formation of the extracellular matrix in vitro, due to tardy procollagen processing by collagen C‐proteinase/BMP‐1, and difficulties in relating this matrix to cell numbers in experimental samples. Experimental approach: The Scar‐in‐a‐Jar model provided, in vitro, the complete biosynthetic cascade of collagen matrix formation including complete conversion of procollagen by C‐proteinase/BMP‐1, its subsequent extracellular deposition and lysyl oxidase‐mediated cross‐linking, achieved by applying the biophysical principle of macromolecular ‘crowding’. Collagen matrix deposition, velocity and morphology can be controlled using negatively charged ‘crowders’ in a rapid (2 days) mode or a mixture of neutral ‘crowders’ in an accelerated (6 days) mode. Combined with quantitative optical bioimaging, this novel system allows for in situ assessment of the area of deposited collagen(s) per cell. Key results: Optical evaluation of known and novel antifibrotic compounds effective at the epigenetic, post‐transcriptional/translational/secretional level correlated excellently with corresponding biochemical analyses. Focusing on quantitation of deposited collagen, the Scar‐in‐a‐Jar was most effective in assessing novel inhibitors that may have multiple targets, such as microRNA29c, found to be a promising antifibrotic agent. Conclusions and implications: This novel screening system supersedes current in vitro fibroplasia models, as a fast, quantitative and non‐destructive technique. This method distinguishes a reduction in collagen I deposition, excluding collagen cross‐linking, and allows full evaluation of inhibitors of C‐proteinase/BMP‐1 and other matrix metalloproteinases.de_CH
dc.language.isoende_CH
dc.publisherThe British Pharmacological Societyde_CH
dc.relation.ispartofBritish Journal of Pharmacologyde_CH
dc.rightsLicence according to publishing contractde_CH
dc.subject.ddc572: Biochemiede_CH
dc.titleThe Scar‐in‐a‐Jar : studying potential antifibrotic compounds from the epigenetic to extracellular level in a single wellde_CH
dc.typeBeitrag in wissenschaftlicher Zeitschriftde_CH
dcterms.typeTextde_CH
zhaw.departementLife Sciences und Facility Managementde_CH
zhaw.organisationalunitInstitut für Chemie und Biotechnologie (ICBT)de_CH
dc.identifier.doi10.1111/j.1476-5381.2009.00387.xde_CH
zhaw.funding.euNode_CH
zhaw.issue5de_CH
zhaw.originated.zhawNode_CH
zhaw.pages.end1209de_CH
zhaw.pages.start1196de_CH
zhaw.publication.statuspublishedVersionde_CH
zhaw.volume158de_CH
zhaw.publication.reviewPeer review (Publikation)de_CH
zhaw.webfeedMetabolic Tissue Engineeringde_CH
Appears in collections:Publikationen Life Sciences und Facility Management

Files in This Item:
There are no files associated with this item.
Show simple item record
Chen, C. Z. C., Fish, P. V., Peng, Y. X., Wang, Z. B., Kaar, J. L., Koepsel, R. R., Russell, A. J., Lareu, R. R., & Raghunath, M. (2009). The Scar‐in‐a‐Jar : studying potential antifibrotic compounds from the epigenetic to extracellular level in a single well. British Journal of Pharmacology, 158(5), 1196–1209. https://doi.org/10.1111/j.1476-5381.2009.00387.x
Chen, C.Z.C. et al. (2009) ‘The Scar‐in‐a‐Jar : studying potential antifibrotic compounds from the epigenetic to extracellular level in a single well’, British Journal of Pharmacology, 158(5), pp. 1196–1209. Available at: https://doi.org/10.1111/j.1476-5381.2009.00387.x.
C. Z. C. Chen et al., “The Scar‐in‐a‐Jar : studying potential antifibrotic compounds from the epigenetic to extracellular level in a single well,” British Journal of Pharmacology, vol. 158, no. 5, pp. 1196–1209, 2009, doi: 10.1111/j.1476-5381.2009.00387.x.
CHEN, C.Z.C., P.V. FISH, Y.X. PENG, Z.B. WANG, J.L. KAAR, R.R. KOEPSEL, A.J . RUSSELL, R.R. LAREU und M. RAGHUNATH, 2009. The Scar‐in‐a‐Jar : studying potential antifibrotic compounds from the epigenetic to extracellular level in a single well. British Journal of Pharmacology. 2009. Bd. 158, Nr. 5, S. 1196–1209. DOI 10.1111/j.1476-5381.2009.00387.x
Chen, C.Z.C., P.V. Fish, Y.X. Peng, Z.B. Wang, J.L. Kaar, R.R. Koepsel, A.J . Russell, R.R. Lareu, and M. Raghunath. 2009. “The Scar‐in‐a‐Jar : Studying Potential Antifibrotic Compounds from the Epigenetic to Extracellular Level in a Single Well.” British Journal of Pharmacology 158 (5): 1196–1209. https://doi.org/10.1111/j.1476-5381.2009.00387.x.
Chen, C. Z. C., et al. “The Scar‐in‐a‐Jar : Studying Potential Antifibrotic Compounds from the Epigenetic to Extracellular Level in a Single Well.” British Journal of Pharmacology, vol. 158, no. 5, 2009, pp. 1196–209, https://doi.org/10.1111/j.1476-5381.2009.00387.x.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.